M1 Kliniken AG

M1 Kliniken AG publishes Q1 figures 2023: Strong growth and disproportionate increase in operating result

M1 Kliniken AG: Attila Strauss, buy

M1 Kliniken AG: Kilian Brenske, buy

M1 Kliniken AG decides to start share buyback

M1 Kliniken AG publishes preliminary figures for financial year 2022

M1 Kliniken AG: Kilian Brenske, buy

M1 Kliniken AG: Attila Strauss, buy

Expansion of the Management Board of M1 Kliniken AG

Expansion of the Management Board of M1 Kliniken AG

M1 Kliniken AG announces figures for Q3 2022: Group continues the expansion course with development of a new country market

M1 Kliniken AG announces financials for H1-2022: positive business development despite cooling of general consumer climate

M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment

M1 Kliniken AG: Supervisory Board adopts (consolidated) financial statements 2021 of M1 Kliniken AG. No deviations from the preliminary figures for financial year 2021 published at the end of March

M1 Kliniken AG publishes preliminary figures for financial year 2021: revenue rises to € 315 million; pre-tax profit amounts to € 14.4 million

M1 Kliniken AG continues successful development in Q4 2021

M1 Kliniken AG announces financials for Q3-2021: forecasts confirmed after good development of treatment and business figures

M1 Kliniken AG continues growth course

M1 Kliniken AG publishes figures for the 1st half of 2021: stable business development despite continued Corona burdens

M1 Kliniken AG successfully held its Annual General Meeting 2021

M1 Kliniken AG publishes figures for the 1st quarter of 2021: successful start to 2021 with significant increase in revenues and earnings in both business segments

M1 Kliniken AG publishes preliminary figures for the 2020 financial year: revenue rises to € 160 million; net profit for the year amounts to € 7.4 million.

M1 Kliniken AG disposes subsidiary ‘M1 Aesthetics GmbH’ to HAEMATO AG – Transfer of the holding of the company within the scope of a capital increase in kind of HAEMATO AG AG:

M1 Kliniken AG disposes subsidiary ‘M1 Aesthetics GmbH’ to HAEMATO AG – Transfer of the holding of the company within the scope of a capital increase in kind of HAEMATO AG

M1 Kliniken AG: Mr. Patrick Brenske joins the board of HAEMATO AG. Promotion of the product business as core task of the integration of the Haemato Group into the M1 Kliniken AG – Group

M1 Kliniken AG: Number of treatments increase by almost 20 % in Q3-2020. Comprehensive hygiene concept ensures continuation of treatment activities.

M1 Kliniken AG announces its financials for the 1st half of 2020

M1 Kliniken AG: Successfully conducts the annual general meeting. Despite temporary losses due to the lock-down, the Management Board confirms its assessment of the company’s growth prospects.

M1 Kliniken AG: M1 Kliniken AG acquires 48 % of HAEMATO AG – concentration of both companies on their respective core competencies

M1 Kliniken AG: acquires ca. 48 % of the shares of HAEMATO AG – transfer of the shares in a capital increase against contribution in kind of M1 Kliniken AG

M1 Kliniken AG: Publishes consolidated financial statements 2019 – encouraging resumption of patient treatments – shortened notice periods for Annual General Meeting on 09 July 2020